Kite Investigator-Sponsored Research
Kite’s Investigator-Sponsored Research (ISR) program supports scientifically meritorious proposals in its therapeutic areas. Applicants submit a concise online form, and approved studies receive drug supply, funding, or operational support under a formal agreement.
Eligibility Criteria:
-
Organization Types: Clinics, universities, academic medical centers, cooperative groups, research institutes.
-
Excluded Applicants: Individual physicians or private-practice groups; Kite/Gilead employees; persons debarred or ineligible for healthcare programs.
-
Investigator Qualifications: Principal Investigator with a relevant advanced degree; for patient-involving studies, a valid medical license (or equivalent).
-
Site Capabilities: Adequate technical, operational, and logistical resources to conduct the study.
Submission Requirements & Process:
-
Online Submission: Complete and submit the ISR proposal form via Kite’s portal, providing a short synopsis of your research. All fields must be filled before submission.
-
Scientific Merit & Budget: Proposals must generate new medical knowledge; budgets must be reasonable and aligned to the work proposed.
-
Review: Cross-functional Kite committees (Medical, Regulatory, Operations) review submissions on a regular schedule.
-
Timeline: Expect feedback—approval, questions, or rejection—within one month of submission.
-
Agreement & Execution: Approved studies require a written support agreement. Sponsors must adhere to protocol-development and contract-execution deadlines. Kite does not guarantee support for any proposal.
Where to Go for Further Information & Submission:
Submit your ISR proposal and access guidance at Kite’s Investigator-Sponsored Research Portal.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023